SCHEMBL29303101

SCHEMBL29303101

O=C1C2CC2CN1c1cc(C2CC2)cn2cc(COc3cnnc(Cl)c3)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30997744 1.00 — —
SCHEMBL24737788 0.83 MCHR1 (0.31) —
SCHEMBL30997874 0.83 MCHR1 (0.31) —
SCHEMBL24737473 0.78 BTK (0.32) —
SCHEMBL24738864 0.78 BTK (0.32) —
SCHEMBL24740039 0.78 BTK (0.31) —
SCHEMBL29879631 0.78 BTK (0.31) —
SCHEMBL29879668 0.78 BTK (0.31) —
Hydrochloric Acid SCHEMBL31658596 0.77 BTK (0.32) —
SCHEMBL24737797 0.76 SCN9A (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228488-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN TAKEDA PHARMACEUTICALS CO (JP) 2024-07-11 — — US disclosed
US-20240228488-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN TAKEDA PHARMACEUTICALS CO (JP) 2024-07-11 — — US disclosed
Send feedback